Unlocking Cross-Border Growth: Modern Go-to-Market Strategies in Trade Finance
click here to discover importer exporter profiles & logistic partners
Shipments
Trading Partners
Markets
Products/HS Code
Exports Data of
sanofi aventis
h-1138, hungary, budapest, hungary commercial and servicing private company l, 1, hungary
sanofi aventis is based out of hungary with 12 export shipments recorded in global import export data.
Trade Trends of sanofi aventis
from Jan 2022 to Sept 2025Shipments Imported: 0
As Buyer Trade Value (USD): $0
Shipments Exported: 12
As Supplier Trade Value (USD): $61.67 K
Import and Export shipments of "sanofi aventis"
As Supplier
| Consignee Name | Shipper Name | HS Code | Shipment Weight (kg) | Product Keywords | Shipment Date |
|---|---|---|---|---|---|
| 300431 | 0.926 | 1. Samples supplied for state registration in the Republic of Uzbekistan: Medicinal product "SOLIQUA" 300IU/+50 INJ SOLO5 M24 XO. Batch 4F023A. Solution for subcutaneous administration of insulin glargine + lixisenatide in 1 ml. - coll. 5 pcs., weight: 0.926 | Jun 27, 2024 | ||
gu center for pharmaceutical safety products | sanofi aventis | 300431 | 0.926 | 1. Samples supplied for state registration in the Republic of Uzbekistan: Medicinal product "SOLIQUA" 300IU/+50 INJ SOLO5 M24 XO. Batch 4F023A. Solution for subcutaneous administration of insulin glargine + lixisenatide in 1 ml. - coll. 5 pcs., weight: 0.926 | Jun 27, 2024 |
gu center for pharmaceutical safety products | sanofi aventis | 300431 | 0.926 | 1. Samples supplied for state registration in the Republic of Uzbekistan: Medicinal product "SOLIQUA" 300IU/+50 INJ SOLO5 M24 XO. Batch 4F023A. Solution for subcutaneous administration of insulin glargine + lixisenatide in 1 ml. - coll. 5 pcs., weight: 0.926 | Jun 27, 2024 |
gu center for pharmaceutical safety products | sanofi aventis | 300431 | 0.926 | 1. Samples supplied for state registration in the Republic of Uzbekistan: Medicinal product "SOLIQUA" 300IU/+50 INJ SOLO5 M24 XO. Batch 4F023A. Solution for subcutaneous administration of insulin glargine + lixisenatide in 1 ml. - coll. 5 pcs., weight: 0.926 | Jun 27, 2024 |
gu center for pharmaceutical safety products | sanofi aventis | 300431 | 0.926 | 1. Samples supplied for state registration in the Republic of Uzbekistan: Medicinal product "SOLIQUA" 300IU/+50 INJ SOLO5 M24 XO. Batch 4F023A. Solution for subcutaneous administration of insulin glargine + lixisenatide in 1 ml. - coll. 5 pcs., weight: 0.926 | Jun 27, 2024 |
Trademo turns 3B+ shipment records and 15M+ company profiles into actionable data for trade prospecting. Subscribe to Trademo Intel to grow the pipeline.
Solutions Built for Every Stage of Global Trade
Global Trade Management
Discover end-to-end compliance automation across classification, screening, and duties.
Know more
Intel
Discover high-potential prospects, qualify opportunities, and grow your pipeline.
Know more
SourceAtlas
Discover suppliers, compare sourcing markets, and make smarter sourcing decisions.
Know more
Trading Partners of sanofi aventis
Top Companies "sanofi aventis" is exporting to (by Value USD)
| Buyer | 2024 | 2023 | 2022 |
|---|---|---|---|
llc korex | - | - | 59.51 K |
gu center for pharmaceutical safety products | 717.38 | 1.44 K | - |
Markets in which sanofi aventis trades
Top Countries "sanofi aventis" is exporting to (by Value USD)
| Importing Country | 2024 | 2023 | 2022 |
|---|---|---|---|
 russia | - | - | 59.51 K |
 uzbekistan | 717.38 | 1.44 K | - |
Products/HS Codes traded by sanofi aventis
Top HS Codes Exported by "sanofi aventis"
USD 3.35 K | 58.33%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
USD 717.38 | 16.67%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. -- Containing insulin
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. -- Containing insulin
USD 343.32 | 16.67%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other, containing antibiotics
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other, containing antibiotics
USD 57.25 K | 8.33%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale
Intel
Identify in-market buyers, prioritize high-potential accounts, and accelerate pipeline growth.
Similar Companies to sanofi aventis
Companies exporting similar products as of "sanofi aventis" in hungary
Companies exporting similar HS Codes as of "sanofi aventis" in hungary
Other Buyers and Suppliers in hungary who deal in similar products like sanofi aventis
Other suppliers who export similar products like "sanofi aventis"
Explore Transformation Stories
How a US Freight Forwarder Generated
4x More Leads at $1 Cost Per Lead
Trademo’s global trade intelligence platform has allowed us to find leads easily, boosting the team’s productivity and making the process simpler.
Iliana Rodriguez
Operations Team Leader
Frequently Asked Questions
What products does Sanofi Aventis export?
Sanofi Aventis is known to export veterinary medicine, and related goods, as per verified global trade insights.
Who are the top buyers purchasing from Sanofi Aventis?
According to trade records, some of the top buyers of Sanofi Aventis include Llc Korex And Gu Center For Pharmaceutical Safety Products.
Which countries does Sanofi Aventis trade with?
Customs data shows that Sanofi Aventis is most active in trade with countries such as Russia And Uzbekistan.
How many shipments has Sanofi Aventis in last 12 months?
In last 12 months, Sanofi Aventis has been linked to 12 verified shipments tracked through international trade data.
What is the total export value of Sanofi Aventis in last 12 months?
The total recorded export value of Sanofi Aventis is estimated at $61.67 K till date, based on aggregated global shipment sources.
How can I analyze Sanofi Aventis global trade network?
With Trademo, you can explore Sanofi Aventis complete trade ecosystem including buyers, manufacturers, shipment volumes, and trade routes, helping you identify opportunities and risks.
APIs
Data License
Plans
Directories
Company
Location
United States
3000 El Camino Real, Building 4, Suite 200, Palo Alto, California 94306
India
2nd Floor, Plot No. 136, Sector 44, Gurugram, Haryana 122003
All rights reserved | Terms of use Copyright ©2025 Trademo Technologies Inc.